TY - JOUR
T1 - Dental pulp-derived mesenchymal stem cells for modeling genetic disorders
AU - Masuda, Keiji
AU - Han, Xu
AU - Kato, Hiroki
AU - Sato, Hiroshi
AU - Zhang, Yu
AU - Sun, Xiao
AU - Hirofuji, Yuta
AU - Yamaza, Haruyoshi
AU - Yamada, Aya
AU - Fukumoto, Satoshi
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/3/1
Y1 - 2021/3/1
N2 - A subpopulation of mesenchymal stem cells, developmentally derived from multipotent neural crest cells that form multiple facial tissues, resides within the dental pulp of human teeth. These stem cells show high proliferative capacity in vitro and are multipotent, including adipogenic, myogenic, osteogenic, chondrogenic, and neurogenic potential. Teeth containing viable cells are harvested via minimally invasive procedures, based on various clinical diagnoses, but then usually discarded as medical waste, indicating the relatively low ethical considerations to reuse these cells for medical applications. Previous studies have demonstrated that stem cells derived from healthy subjects are an excellent source for cell-based medicine, tissue regeneration, and bioengineering. Furthermore, stem cells donated by patients affected by genetic disorders can serve as in vitro models of disease-specific genetic variants, indicating additional applications of these stem cells with high plasticity. This review discusses the benefits, limitations, and perspectives of patient-derived dental pulp stem cells as alternatives that may complement other excellent, yet incomplete stem cell models, such as induced pluripotent stem cells, together with our recent data.
AB - A subpopulation of mesenchymal stem cells, developmentally derived from multipotent neural crest cells that form multiple facial tissues, resides within the dental pulp of human teeth. These stem cells show high proliferative capacity in vitro and are multipotent, including adipogenic, myogenic, osteogenic, chondrogenic, and neurogenic potential. Teeth containing viable cells are harvested via minimally invasive procedures, based on various clinical diagnoses, but then usually discarded as medical waste, indicating the relatively low ethical considerations to reuse these cells for medical applications. Previous studies have demonstrated that stem cells derived from healthy subjects are an excellent source for cell-based medicine, tissue regeneration, and bioengineering. Furthermore, stem cells donated by patients affected by genetic disorders can serve as in vitro models of disease-specific genetic variants, indicating additional applications of these stem cells with high plasticity. This review discusses the benefits, limitations, and perspectives of patient-derived dental pulp stem cells as alternatives that may complement other excellent, yet incomplete stem cell models, such as induced pluripotent stem cells, together with our recent data.
UR - http://www.scopus.com/inward/record.url?scp=85101267927&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101267927&partnerID=8YFLogxK
U2 - 10.3390/ijms22052269
DO - 10.3390/ijms22052269
M3 - Review article
C2 - 33668763
AN - SCOPUS:85101267927
SN - 1661-6596
VL - 22
SP - 1
EP - 18
JO - International journal of molecular sciences
JF - International journal of molecular sciences
IS - 5
M1 - 2269
ER -